Skip to content

<img width="250" height="38" src="https://intrommune.com/wp-content/uploads/2021/06/Intrommune-logo.png" class="custom-logo" alt="Intrommune Therapeutics" decoding="async" srcset="https://intrommune.com/wp-content/uploads/2021/06/Intrommune-logo.png 1x, https://intrommune.com/wp-content/uploads/2021/06/Intrommune-logo-2x.png 2x" />

About Us
Our Science
- Overview
- Multifood INT302
News & Resources
Blog
Contact

<img width="250" height="38" src="https://intrommune.com/wp-content/uploads/2021/06/Intrommune-logo.png" class="custom-logo" alt="Intrommune Therapeutics" decoding="async" srcset="https://intrommune.com/wp-content/uploads/2021/06/Intrommune-logo.png 1x, https://intrommune.com/wp-content/uploads/2021/06/Intrommune-logo-2x.png 2x" />

Kelley Nelson

Intrommune Expands and Strengthens Senior Leadership Team

Press Releases / By Kelley Nelson

Intrommune Therapeutics Names Nandini Murthy as Head of Regulatory

Press Releases / By Kelley Nelson

Intrommune Announces Expanded Scope of Phase 1 OMEGA Study in Adults with Peanut Allergy

Press Releases / By Kelley Nelson

This Startup is Creating a Toothpaste for Your Peanut Allergy

In the News / By Kelley Nelson

About Us
Our Science
- Overview
- Multifood INT302
News & Resources
Blog
Contact

About Us
Our Science
Multifood INT302
News & Resources
Contact

Sign up for Intrommune's newsletter and stay informed of company developments.

Email Address *

Please do not fill in this field.

About Us
Our Science
Multifood INT302
News & Resources
Contact

Sign up for Intrommune's newsletter and stay informed of company developments.

Email Address *

Please do not fill in this field. Please do not fill in this field.

Copyright © 2025 Intrommune Therapeutics | Privacy Policy | Accessibility Statement